SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
13-Nov-23 2:49 PM View: | Intercept Pharmaceuticals, ... (ICPT) | 08-Nov-23 | Disposition | 14,669 | $19.00 | $278,711.00 | (58%) 25.45K to 10.78K | |
13-Nov-23 2:49 PM View: | Intercept Pharmaceuticals, ... (ICPT) | 08-Nov-23 | Disposition (change in control) | 10,782 | $19.00 | $204,858.00 | (100%) 10.78K to 0 | |
31-Jan-23 4:06 PM View: | Intercept Pharmaceuticals, ... (ICPT) | 27-Jan-23 | Grant | 9,800 | -- | -- | 63% 15.65K to 25.45K | |
03-Jan-23 4:04 PM View: | Intercept Pharmaceuticals, ... (ICPT) | 31-Dec-22 | Payment of Exercise | 675 | $12.37 | $8,349.75 | (4%) 16.33K to 15.65K | |
06-Sep-22 4:01 PM View: | Intercept Pharmaceuticals, ... (ICPT) | 01-Sep-22 | Payment of Exercise | 429 | $18.06 | $7,747.74 | (3%) 16.75K to 16.33K | |
31-Jan-22 4:16 PM View: | Intercept Pharmaceuticals, ... (ICPT) | 27-Jan-22 | Grant | 3,600 | -- | -- | 27% 13.15K to 16.75K | |
04-Jan-22 4:18 PM View: | Intercept Pharmaceuticals, ... (ICPT) | 01-Jan-22 | Payment of Exercise | 35 | $16.29 | $570.15 | (< 1%) 13.19K to 13.15K | (5%) |
04-Jan-22 4:18 PM View: | Intercept Pharmaceuticals, ... (ICPT) | 31-Dec-21 | Payment of Exercise | 515 | $16.29 | $8,389.35 | (4%) 13.71K to 13.19K | (5%) |
05-Oct-21 5:29 PM View: | Intercept Pharmaceuticals, ... (ICPT) | 01-Oct-21 | Payment of Exercise | 30 | $15.22 | $456.60 | (< 1%) 13.73K to 13.71K | 2% |
03-Sep-21 7:01 PM View: | Intercept Pharmaceuticals, ... (ICPT) | 01-Sep-21 | Payment of Exercise | 524 | $15.05 | $7,886.20 | (4%) 14.26K to 13.73K | (< 1%) |
02-Jul-21 10:00 PM View: | Intercept Pharmaceuticals, ... (ICPT) | 01-Jul-21 | Payment of Exercise | 30 | $20.47 | $614.10 | (< 1%) 14.29K to 14.26K | (< 1%) |
05-Apr-21 7:03 PM View: | Intercept Pharmaceuticals, ... (ICPT) | 01-Apr-21 | Payment of Exercise | 29 | $24.28 | $704.12 | (< 1%) 14.32K to 14.29K | 0% |